Brief: Dancann Pharma Reports Q1 Net Sales KDKK 1,266 Vs KDKK 874
18/05/2022 16:06
May 18 (Reuters) - Dancann Pharma A/S DANCAN.TE :
* NET SALES IN Q1 KDKK 1,266 VERSUS KDKK 874
* QTRLY LOSS PER SHARE DKK 0.01
Source text for Eikon: ID:nWkr76Ktpf
Further company coverage: DANCAN.TE
((reuters.briefs@thomsonreuters.com;))
Recent news on Dancann Pharma A/S
See all newsBrief: Dancann Pharma Says Jeppe Krog Rasmussen Resigns As CEO
Brief: Dancann Pharma Says Resolved To Apply For Delisting From Spotlight Stock Market, Subject To Approval By The General Meeting
Brief: Dancann Pharma Says Rights Issue Has Been Subscribed For A Total Of Approximately 77%
Brief: Dancann Pharma A/S Postpones Quarterly Report For Q2 2022
Brief: Dancann Pharma Reports Q1 Net Sales KDKK 1,266 Vs KDKK 874